Seminar Series - Jeff MacKeigan, PhD

The MSU Seminar Series

Jeff MacKeigan, PhD

Associate Professor

Center for Cancer and Cell Biology

Van Andel Research Institute

“Precision Medicine: The Genomic Landscape of a Tumor Syndrome.”

Presentation Overview

Cancer genomics and cancer biology are both equally poised for impact in oncology from a drug discovery and therapeutic standpoint. Cancer genomic data coupled with the right functional screening approach can be exploited to reveal new disease biology and new drug targets. Our research spans a variety of cancers and technologies. We also use our cancer biology expertise and pathway knowledge to study tuberous sclerosis complex (TSC). TSC is a rare disease, characterized by mutations in TSC1 or TSC2, two tumor suppressor genes located in the mTOR pathway. Often diagnosed during childhood, the disease causes tumors in major organs including the brain, kidneys, skin, and heart. We will present our latest data on new and existing therapeutic targets along with the genomic landscape of this disease.

Monday, December 19, 2016

12:00 PM – 1:00 PM
220 Secchia Center
Videoconference to 1310 Anthony Hall
Host: Dr. Jose Teixeira